Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Dow
Mallinckrodt
Harvard Business School

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Bowling v. Hasbro, Inc. (D.R.I. 2005)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Bowling v. Hasbro, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Bowling v. Hasbro, Inc. (D.R.I. 2005)

Date Filed Document No. Description Snippet Link To Document
2007-08-13 100 Exhibit I "starting U.S. Patent No. 4,444,779 (the "'779 Patent"). point for…obvious at the time the inven- patent claims asserted by plaintiff patent holder were tion was made…in the patent in suit. compound is depicted as: Takeda owns U.S. Patent 4,687,777…considered Takeda's U.S. Patent 4,287,200 prosecution history of the patent contained a statement…maturity-onset diabetes," Patent 4,340,605, U.S. Patent 4,438,141, and not compound External link to document
2007-12-03 126 Exhibit C Patent No. 4,444,779 (the "'779 Patent"). The skill in the art…him on the brief were Barbara patent claims asserted by plaintiff patent holder were L. Moore, Kathleen…quot; The patent is directed to "com- New York, following a bench trial, that U.S. Patent … also held that the '777 patent had not been procured '777 patent, claim 2. Pioglitazone is referred… Patent 4,340,605, U.S. Patent 4,438,141, and U.S. argues that the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Merck
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.